TNFRSF17 and schizophrenia: Among them, AGER (schizophrenia), CD40 (schizophrenia & bipolar), TNFRSF17 (schizophrenia), ACE (schizophrenia & Alzheimer’s) and SEPRING1 (schizophrenia) have drugs approved or in advanced clinical trials for several indications including cardiovascular and autoimmune conditions.